NCT00161681

Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMS

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Levonorgestrel 90 Mcg and Ethinyl Estradiol 20 Mcg in a Continuous Daily Regimen on Menstrual Cycle-Related Symptoms

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 200 (planned)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: Female
• Age: 18 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether LNG/EE is effective in the treatment of menstrual cycle related symptoms.

Conditions

• Premenstrual Syndrome

Interventions

Type	Name	Description
DRUG	Levonorgestrel/Ethinyl Estradiol

Timeline

• Start date: 2005-07-01
• Primary completion: 2006-08-01
• Completion: 2006-08-01
• First posted: 2005-09-12
• Last updated: 2013-02-08

Locations

48 sites across 1 country: United States